Your browser doesn't support javascript.
loading
Postprandial renal haemodynamic effects of the dipeptidyl peptidase-4 inhibitor linagliptin versus the sulphonylurea glimepiride in adults with type 2 diabetes (RENALIS): A predefined substudy of a randomized, double-blind trial.
Muskiet, Marcel H A; Tonneijck, Lennart; Smits, Mark M; Kramer, Mark H H; Ouwens, D Margriet; Hartmann, Bolette; Holst, Jens J; Danser, A H Jan; Joles, Jaap A; van Raalte, Daniël H.
Afiliação
  • Muskiet MHA; Diabetes Center, Department of Internal Medicine, Amsterdam University Medical Centers, Location VUMC, Amsterdam, The Netherlands.
  • Tonneijck L; Diabetes Center, Department of Internal Medicine, Amsterdam University Medical Centers, Location VUMC, Amsterdam, The Netherlands.
  • Smits MM; Diabetes Center, Department of Internal Medicine, Amsterdam University Medical Centers, Location VUMC, Amsterdam, The Netherlands.
  • Kramer MHH; Diabetes Center, Department of Internal Medicine, Amsterdam University Medical Centers, Location VUMC, Amsterdam, The Netherlands.
  • Ouwens DM; Institute of Clinical Biochemistry and Pathobiochemistry, German Diabetes Center, Dusseldorf, Germany.
  • Hartmann B; German Center for Diabetes Research (DZD), Muenchen-Neuherberg, Germany.
  • Holst JJ; Department of Endocrinology, Ghent University Hospital, Ghent, Belgium.
  • Danser AHJ; Department of Biomedical Sciences, Panum Institute, University of Copenhagen, Copenhagen, Denmark.
  • Joles JA; Department of Biomedical Sciences, Panum Institute, University of Copenhagen, Copenhagen, Denmark.
  • van Raalte DH; Department of Internal Medicine, Division of Pharmacology and Vascular Medicine, Erasmus University Medical Center, Rotterdam, The Netherlands.
Diabetes Obes Metab ; 24(1): 115-124, 2022 01.
Article em En | MEDLINE | ID: mdl-34580975
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 2 / Inibidores da Dipeptidil Peptidase IV Tipo de estudo: Clinical_trials Limite: Adult / Humans Idioma: En Revista: Diabetes Obes Metab Assunto da revista: ENDOCRINOLOGIA / METABOLISMO Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Holanda
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 2 / Inibidores da Dipeptidil Peptidase IV Tipo de estudo: Clinical_trials Limite: Adult / Humans Idioma: En Revista: Diabetes Obes Metab Assunto da revista: ENDOCRINOLOGIA / METABOLISMO Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Holanda